Company Hi-Great Group Holding Company

Equities

HIGR

US4283711087

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 01:10:02 19/10/2022 am IST			5-day change	1st Jan Change
0.0178 ^USD	-98.22%		-.--%	-.--%

2023	Hi-Great Group Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Hi-Great Group Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Hi-Great Group Holding Company holds a license agreement for New Business Plan with the KRAS gene, which is among the most frequently mutated genes across all cancers, including pancreatic, lung, and colorectal. The Company is engaged in marketing, selling, and distributing SellaCare, Inc's organic longevity health supplement. The Company is in license agreement with SellaCare, Inc. in the areas of longevity and additional health benefits and it also expands into the cosmetic sector as an overall sustainable revenue platform.

USD in Million	2021	Weight	2022	Weight	Delta
Agritourism and Herbal Supplements 100.0 %	0	100.0 %	0	100.0 %	-21.33%

USD in Million	2021	Weight	2022	Weight	Delta
United States 100.0 %	0	100.0 %	0	100.0 %	-21.33%

Managers	Title	Age	Since
Ho Yang Jun CEO	Chief Executive Officer	59	25/20/25
Soon Yang Ho DFI	Director of Finance/CFO	53	14/19/14

Members of the board	Title	Age	Since
Ho Yang Jun CEO	Chief Executive Officer	59	25/20/25
Soon Yang Ho DFI	Director of Finance/CFO	53	14/19/14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	100,000,000	17,063,750 ( 17.06 %)	0	17.06 %

Name	Equities	%	Valuation
Ho Soon Yang 32.50 %	32,501,000	32.50 %	578 518 $
Jun Ho Yang 31.50 %	31,500,000	31.50 %	560 700 $
Shuchan Yu 7.935 %	7,935,250	7.935 %	141 247 $
Chihhsiang Tu 5.000 %	5,000,000	5.000 %	89 000 $
Chugwen You 5.000 %	5,000,000	5.000 %	89 000 $
Madeline Choi 1.000 %	1,000,000	1.000 %	17 800 $

Hi-Great Group Holding Co.

621 South Virgil Avenue Suite 460

90005, Los Angeles

address Hi-Great Group Holding Company(HIGR)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
HI-GREAT GROUP HOLDING COMPANY	-.--%	1.78M
MODERNA, INC.	+29.03%	48.16B
IQVIA HOLDINGS INC.	-0.10%	41.73B
LONZA GROUP AG	+43.45%	41.03B
CELLTRION, INC.	-5.26%	28.77B
ICON PUBLIC LIMITED COMPANY	+11.48%	25.59B
ALNYLAM PHARMACEUTICALS, INC.	-22.74%	18.96B
BIO-TECHNE CORPORATION	+9.06%	12.92B
MEDPACE HOLDINGS, INC.	+30.01%	12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.51%	11.77B

Other Biotechnology & Medical Research